253 related articles for article (PubMed ID: 27183221)
41. Financial Ties Between Emergency Physicians and Industry: Insights From Open Payments Data.
Fleischman W; Ross JS; Melnick ER; Newman DH; Venkatesh AK
Ann Emerg Med; 2016 Aug; 68(2):153-158.e4. PubMed ID: 26973175
[TBL] [Abstract][Full Text] [Related]
42. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
Ansari B
Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
[TBL] [Abstract][Full Text] [Related]
43. Medicare Part D payments for neurologist-prescribed drugs.
De Lott LB; Burke JF; Kerber KA; Skolarus LE; Callaghan BC
Neurology; 2016 Apr; 86(16):1491-8. PubMed ID: 27009256
[TBL] [Abstract][Full Text] [Related]
44. Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.
Inoue K; Figueroa JF; DeJong C; Tsugawa Y; Orav EJ; Shen C; Kazi DS
Circ Cardiovasc Qual Outcomes; 2021 May; 14(5):e007521. PubMed ID: 33966446
[TBL] [Abstract][Full Text] [Related]
45. The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments.
Winn AN; Mitchell AP; Fergestrom N; Neuner JM; Trogdon JG
J Gen Intern Med; 2021 Jul; 36(7):1858-1866. PubMed ID: 33904046
[TBL] [Abstract][Full Text] [Related]
46. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
Pham-Kanter G; Mello MM; Lehmann LS; Campbell EG; Carpenter D
J Gen Intern Med; 2017 Jul; 32(7):767-774. PubMed ID: 28265803
[TBL] [Abstract][Full Text] [Related]
47. Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? : A Systematic Review.
Mitchell AP; Trivedi NU; Gennarelli RL; Chimonas S; Tabatabai SM; Goldberg J; Diaz LA; Korenstein D
Ann Intern Med; 2021 Mar; 174(3):353-361. PubMed ID: 33226858
[TBL] [Abstract][Full Text] [Related]
48. Industry ties in otolaryngology: initial insights from the physician payment sunshine act.
Rathi VK; Samuel AM; Mehra S
Otolaryngol Head Neck Surg; 2015 Jun; 152(6):993-9. PubMed ID: 25779469
[TBL] [Abstract][Full Text] [Related]
49. Industry Relationships With Pediatricians: Findings From the Open Payments Sunshine Act.
Parikh K; Fleischman W; Agrawal S
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244857
[TBL] [Abstract][Full Text] [Related]
50. Analysis of current financial relationships between emergency physicians and industry.
Niforatos JD; Boas S; Hertz S; Ozgur A; Raja AS
Am J Emerg Med; 2019 Apr; 37(4):722-725. PubMed ID: 30611579
[TBL] [Abstract][Full Text] [Related]
51. Pharmaceutical industry-sponsored meals are associated with increased prescriptions and Medicare spending for dupilumab among dermatologists in the United States.
Murayama A
J Eval Clin Pract; 2024 Apr; 30(3):435-439. PubMed ID: 38149692
[TBL] [Abstract][Full Text] [Related]
52. Deciphering the Sunshine Act: Transparency Regulation and Financial Conflicts in Health Care.
Saver RS
Am J Law Med; 2017 Nov; 43(4):303-343. PubMed ID: 29452562
[TBL] [Abstract][Full Text] [Related]
53. The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.
Bandari J; Turner RM; Jacobs BL; Canes D; Moinzadeh A; Davies BJ
Urol Pract; 2017 Jan; 4(1):14-20. PubMed ID: 28149927
[TBL] [Abstract][Full Text] [Related]
54. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
Jairam V; Yu JB
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
[TBL] [Abstract][Full Text] [Related]
55. Physician payment outlook for 2012: déjà vu.
Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
[TBL] [Abstract][Full Text] [Related]
56. Exploring the Psychiatrist-Industry Financial Relationship: Insight from the Open Payment Data of Centers for Medicare and Medicaid Services.
Rhee TG; Wilkinson ST
Adm Policy Ment Health; 2020 Jul; 47(4):526-530. PubMed ID: 31916072
[TBL] [Abstract][Full Text] [Related]
57. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
[TBL] [Abstract][Full Text] [Related]
58. Industry Payments to Physicians for Opioid Products, 2013-2015.
Hadland SE; Krieger MS; Marshall BDL
Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
[TBL] [Abstract][Full Text] [Related]
59. Industry Payments to Practicing US Rheumatologists, 2014-2019.
Putman MS; Goldsher JE; Crowson CS; Duarte-García A
Arthritis Rheumatol; 2021 Nov; 73(11):2138-2144. PubMed ID: 34164951
[TBL] [Abstract][Full Text] [Related]
60. Receiving Industry Payments is Associated with Prescribing Habits of Tadalafil.
Chua KJ; Li G; Stahl PJ; Hyams ES
Urol Pract; 2019 Sep; 6(5):282-288. PubMed ID: 37317353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
